BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Policy

  Mobilizing Drug Development Efforts Against the Novel Coronavirus

  Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?

  February 14, 2020

   · 

  15 min read

   · 

  Chelsea Weidman Burke
• 

  BioCapital

  A Look at the Top 20 Most Expensive Drugs in the U.S.

  These prices refer to the company’s list price. Most patients will not pay that price because of various forms of health insurance or patient assistance programs.

  February 14, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  BioCapital

  Clinical Catch-Up: February 10-14

  It was a very busy week for clinical trial news. Here’s a look.

  February 14, 2020

   · 

  11 min read

   · 

  Mark Terry
• 

  FDA

  FDA Action Alert: Merck, Baudax Bio, Alder and Esperion

  The U.S. Food and Drug Administration has a busy week planned for drug review. Here’s a look at this week’s schedule.

  February 14, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  How to Research a Position’s Salary

  As you enter the job market (or a new industry) the salary range of positions you’re qualified for is likely top of mind. But how do you figure out what a realistic range is for what you’re after?

  February 14, 2020

   · 

  2 min read

   · 

  Laura Brothers
• Business

  Calliditas Therapeutics - Year-End Report 2019

  In the last quarter of 2019, we achieved a major milestone: the full recruitment of 200 patients for Part A of our pivotal Phase 3 study, NefIgArd.

  February 14, 2020

   · 

  3 min read
• Drug Development

  Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory ResearchPaper demonstrates ensifentrine’s potential in improving lung function and quality of life symptoms

  Verona Pharma plc announces publication of Phase 2b clinical trial results for ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease in the leading peer reviewed journal, Respiratory Research.

  February 14, 2020

   · 

  7 min read
• Drug Development

  New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab)

  First Study to Explore a Treat-to-Target Strategy in Crohn’s Disease Using Endoscopy to Guide Dose Adjustment

  February 14, 2020

   · 

  15 min read
• Business

  Year-End Report 1 January - 31 December 2019

  We summarize 2019 and note that: RaySearch continues to develop at a rapid pace.

  February 14, 2020

   · 

  3 min read
• Business

  IRRAS AB Publishes Interim Report for the Period January to December 2019

  The fourth quarter of 2019 was an important period of progress for IRRAS.

  February 14, 2020

   · 

  4 min read